Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
2.070
-0.080 (-3.72%)
At close: Dec 5, 2025, 4:00 PM EST
2.060
-0.010 (-0.48%)
After-hours: Dec 5, 2025, 7:45 PM EST
Vivos Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Vivos Therapeutics stock have an average target of 6.25, with a low estimate of 5.50 and a high estimate of 7.00. The average target predicts an increase of 201.93% from the current stock price of 2.07.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vivos Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.5 → $5.5 | Strong Buy | Maintains | $6.5 → $5.5 | +165.70% | Dec 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +238.16% | Nov 17, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.2 → $6.5 | Strong Buy | Maintains | $6.2 → $6.5 | +214.01% | Sep 9, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.6 → $6.2 | Strong Buy | Maintains | $6.6 → $6.2 | +199.52% | Apr 15, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Reiterates $6.6 | Strong Buy | Reiterates | $6.6 | +218.84% | Nov 20, 2024 |
Financial Forecast
Revenue This Year
17.73M
from 15.03M
Increased by 17.96%
Revenue Next Year
27.60M
from 17.73M
Increased by 55.64%
EPS This Year
-1.94
from -2.22
EPS Next Year
-1.05
from -1.94
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 20.2M | 31.6M |
| Avg | 17.7M | 27.6M |
| Low | 15.0M | 22.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 34.2% | 78.0% |
| Avg | 18.0% | 55.6% |
| Low | -0.0% | 27.1% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -1.89 | -0.79 |
| Avg | -1.94 | -1.05 |
| Low | -1.96 | -1.17 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.